1. 200PApalutamide (APA) plus androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC): Analysis of pain and fatigue in the TITAN study. (24th November 2019) Authors: Chung, B H; McQuarrie, K; Bjartell, A; Chowdhury, S; Pereira de Santana Gomes, A J; Özgüroğlu, M; Juárez Soto, Á; Merseburger, A S; Uemura, H; Ye, D; Given, R; Miladinovic, B; Li, N; Hudgens, S; Floden, L; Lopez-Gitlitz, A; Chi, K N; Agarwal, N Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 213OEfficacy and safety of apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from SPARTAN: Asian subpopulation. (25th November 2018) Authors: Mainwaring, P; Small, E; Uemura, H; Lee, J Y; Pang, S-T; Marx, G; Kwon, T G; Satoh, T; Bhaumik, A; Cheng, S; Londhe, A; Lopez-Gitlitz, A; Smith, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 804PHealth-related quality of life (HRQoL) after progressive disease (PD) in SPARTAN: A phase III trial of apalutamide (APA) versus placebo (PBO) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC). (23rd October 2018) Authors: Small, E J; Cella, D; McQuarrie, K; Saad, F; Hadaschik, B A; Graff, J N; Uemura, H; Oudard, S; Yu, M K; Hudgens, S; Lopez-Gitlitz, A; Rooney, B; Morris, M; Smith, M R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 851PDPatient-reported outcomes (PROs) from TITAN: A phase III, randomized, double-blind study of apalutamide (APA) versus placebo (PBO) added to androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC). (1st October 2019) Authors: Agarwal, N; McQuarrie, K; Bjartell, A; Chowdhury, S; Gomes, A J P D S; Chung, B H; Özgüroğlu, M; Soto, Á Juárez; Merseburger, A; Uemura, H; Ye, D; Given, R; Miladinovic, B; Dearden, L; Deprince, K; Naini, V; Lopez-Gitlitz, A; Chi, K N Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer. (27th September 2019) Authors: Small, E J; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, B A; Graff, J N; Olmos, D; Mainwaring, P N; Lee, J Y; Uemura, H; De Porre, P; Smith, A A; Zhang, K; Lopez-Gitlitz, A; Smith, M R Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗